Ablation of a Site of Progression With Stereotactic Body Radiation Therapy Extends Sunitinib Treatment From 14 to 22 Months - Concepedia

Concepedia

Publication | Open Access

Ablation of a Site of Progression With Stereotactic Body Radiation Therapy Extends Sunitinib Treatment From 14 to 22 Months

DOI Full Paper Access

31

Citations

23

References

2013

Year

Christopher Straka, D.W. Nathan Kim, Robert Timmerman, Iván Pedrosa, Corbin D. Jacobs, James Brugarolas

Journal of Clinical Oncology

Radiation MedicineSurgical OncologyRadiation TherapyMedicineBrachytherapySurgeryOncologyRadiation Oncology

References

	Year	Citations

Page 1